Asia and Global Semiconductor and Tech Research

Andrew Lu

Thematic (Sector/Industry)

Despite recent strong performance (17% ytd) across US and Taiwan semiconductor index, we are turning a bit cautious here because Taiwan Semi/Tech July sales are somehow below seasonal and below our expectations. If analysts start to factor in 3-4% appreciation on NT$ against US starting July, earnings prospects in 2H16 for semi and tech companies might not be as strong as market estimated earlier. In conclusion, we believe not much sales momentum left over before we see a seasonal semiconductor…

Despite recent strong performance (17% ytd) across US and Taiwan semiconductor index, we are turning a bit cautious here because Taiwan Semi/Tech July sales are somehow below seasonal and below our expectations. If analysts start to factor in 3-4% appreciation on NT$ against US starting July, earnings prospects in 2H16 for semi and tech companies might not be as strong as market estimated earlier. In conclusion, we believe not much sales momentum left over before we see a seasonal semiconductor…

Insights from Taiwan Semi/Tech July Sales

Starting July 14, 2016, TSMC will first report 2Q16 results and provide 3Q16 guidance to kick off semi/tech earnings season. Our report takeaways suggest strengths in foundry, fabless, and display vendors to drive Taiwan semi sales recovery of 17% y/y in June and 8 out 12 vendors reported a beat on 2Q16 sales guidance. Despite the strengths, we saw weaknesses in power amplifier, touch panel, and solar vendors and our semi leading indicator fell to 8% in June 2016 from this year peak of 31% in…

Starting July 14, 2016, TSMC will first report 2Q16 results and provide 3Q16 guidance to kick off semi/tech earnings season. Our report takeaways suggest strengths in foundry, fabless, and display vendors to drive Taiwan semi sales recovery of 17% y/y in June and 8 out 12 vendors reported a beat on 2Q16 sales guidance. Despite the strengths, we saw weaknesses in power amplifier, touch panel, and solar vendors and our semi leading indicator fell to 8% in June 2016 from this year peak of 31% in…

Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Periscope Analytics

Periscope Analytics focuses on event-driven trades across Asia Pacific and provides comprehensive, timely and systematic coverage of index changes to major Asia Pacific indices in a structured manner.

The analysis includes forecasted inclusions and exclusions to all major Asian indices that have significant amount of tracking assets, including estimates of passive buy/sell flow on the stocks. The service also provides commentary and impact of market consultations, ground rule changes, and other events (IPOs, spin-offs, M&A) that could lead to index changes and passive flow.

Periscope Analytics works with multi-strategy hedge funds, proprietary trading firms, stat arb trading groups and long-only investors that invest and trade in the Asia Pacific region with the data being used to trade index rebalances, avoid pre-positioning and passive flow, and to time entry into and exit from stocks.

Event-Driven Trades Across Asia Pacific

Index Rebalance

<ul>
<li>
<a href="https://www.smartkarma.com/entities/mpi-corp" target="_blank" data-smartkarma-citation="entities:11218:1" rel="noopener">Mpi Corp (6223 TT)</a>'s stock price has soared over the last few months, and the stock should be added to a global index in May. </li>
<li>The stock price rally has led to <a href="https://www.smartkarma.com/entities/mpi-corp" target="_blank" data-smartkarma-citation="entities:11218:1" rel="noopener">Mpi Corp (6223 TT)</a> trading at a valuation premium to its peers, but there are some peers that trade at steeper valuations.</li>
<li>Given the strong momentum and the recent risk-on environment, there could be increased positioning over the next week or two and that could take the stock higher from here.</li>
</ul>



Mpi Corp (6223 TT)'s stock price has soared over the last few months, and the stock should be added to a global index in May. 
The stock price rally has led to Mpi Corp (6223 TT) trading at a valuation premium to its peers, but there are some peers that trade at steeper valuations.
Given the strong momentum and the recent risk-on environment, there could be increased positioning over the next week or two and that could take the stock higher from here.


MPI Corp (6223 TT): Stock Going Parabolic as Global Index Inclusion Looms

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

DZT Research

DZT Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analysed the earning revision of component stocks of MS-Taiwan in the past month.</li>
<li>We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.</li>
<li>We highlighted EPS revision on China Steel, TSMC, Delta Electronics, Innolux, Fubon Financial, Elite Material, Asia Vital Components, Formosa Plastics.</li>
</ul>


We analysed the earning revision of component stocks of MS-Taiwan in the past month.
We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.
We highlighted EPS revision on China Steel, TSMC, Delta Electronics, Innolux, Fubon Financial, Elite Material, Asia Vital Components, Formosa Plastics.


MS-Taiwan Index Earning Revision (Mar): China Steel, TSMC, Delta Electronics, Innolux

<ul>
<li>We analysed the earning revision of component stocks of MS-Taiwan in the past month.</li>
<li>We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.</li>
<li>We highlighted EPS revision on CALIWAY BIOPHARMACEUTICALS, Nan Ya Plastics, China Development Financial, MediaTek, TSMC, China Steel, Formosa Plastics.</li>
</ul>


We analysed the earning revision of component stocks of MS-Taiwan in the past month.
We tabulated stocks with the top impact on index's EPS, stocks' EPS revision, and revenue revision.
We highlighted EPS revision on CALIWAY BIOPHARMACEUTICALS, Nan Ya Plastics, China Development Financial, MediaTek, TSMC, China Steel, Formosa Plastics.


MS-Taiwan Index Earning Revision (Dec): CALIWAY, Nan Ya Plastics

Taiwan

Globalwafers Co., Ltd. specializes in silicon wafer manufacturing and also provides solar wafers and crystal rods. The Company possesses a complete production line from ingot growth, slicing, etching, diffusion, polishing to epitaxy. Their products include Epi wafers, polished wafers, etched wafers, ultra thin wafers and deep diffusion wafers.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Globalwafers (6488 TT)

Insights from Taiwan Semi/Tech July Sales

Despite recent strong performance (17% ytd) across US and Taiwan semiconductor index, we are turning a bit cautious here because Taiwan Semi/Tech...

Andrew Lu

Points from Taiwan Semi/Tech 2Q Sales

Starting July 14, 2016, TSMC will first report 2Q16 results and provide 3Q16 guidance to kick off semi/tech earnings season. Our report takeaways...

Andrew Lu

MPI Corp (6223 TT): Stock Going Parabolic as Global Index Inclusion Looms

MPI could be added to a global index in May. The stock has run up and outperformed peers. Valuations are now at a premium. Strong momentum and risk...

Brian Freitas

MS-Taiwan Index Earning Revision (Mar): China Steel, TSMC, Delta Electronics, Innolux

We analyzed MS-Taiwan's consensus for Mar 2026 and highlighted changes of EPS in China Steel (2002 TT), TSMC (2330 TT), Delta Electronics (2308...

Ke Yan, CFA, FRM

MS-Taiwan Index Earning Revision (Dec): CALIWAY, Nan Ya Plastics

We analyzed MS-Taiwan's consensus for Dec 2025 and highlighted changes of EPS in MediaTek (2454 TT), CALIWAY BIOPHARMACEUTICALS (6919 TT), China...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)